G protein-coupled receptor 30 is critical for a progestin-induced growth inhibition in MCF-7 breast cancer cells

Endocrinology

Volumn 143, Issue 9, 2002, Pages 3376-3384

  Ahola, Tytti M ^a   Manninen, Tommi ^a   Alkio, Niina ^a   Ylikomi, Timo ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 30; GESTAGEN; MESSENGER RNA; PROGESTERONE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG RECEPTOR BINDING; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL;

BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; CYCLIN D1; DNA; ESTRADIOL; FLOW CYTOMETRY; G1 PHASE; GENE EXPRESSION; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PROGESTINS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PROGESTERONE; RNA, MESSENGER; TETRACYCLINE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036721112     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2001-211445     Document Type: Article

References (48)

1. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities
2. Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast
3. The effect of age and menstrual cycle upon proliferative activity of the normal human breast
4. Effects of oral contraceptives on breast epithelial proliferation
5. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast
6. Effects of estrogen and estrogen-progestin on mammographic parenchymal density
7. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function
8. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
9. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
10. Hormone replacement therapy in relation to breast cancer
11. Treatment with tamoxifen and progestins for metastatic breast cancer in postmenopausal women: A quantitative review of published randomized clinical trials
12. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines
13. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells
14. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor α, epidermal growth factor receptor, c-fos, and c-myc genes
15. Progestin effects on long-term growth, death, and Bcl-xL in breast cancer cells
16. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines
17. Effects of estradiol and promegestone on human breast cell cultures. An ultrastructural study
18. Progestin effect on cell proliferation and 17β-hydroxysteroid dehydrogenase activity in normal human breast cells in culture
19. Progesterone effect on cell growth, ultrastructural aspect and estradiol receptors of normal human breast epithelial (HBE) cells in culture
20. Physiological action of progesterone in target tissues
21. Biphasic regulation of breast cancer cell growth by progesterone: Role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1)
22. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression
23. Mechanisms of cyclin-dependent kinase inactivation by progestins
24. Specific protection against breast cancers by cyclin D1 ablation
25. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
26. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining
27. Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer
28. Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2
29. Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals
30. Progestin regulation of cellular proliferation
31. A paracrine role for the epithelial progesterone receptor in mammary gland development
32. Progestin upregulates G-protein-coupled receptor 30 in breast cancer cells
33. Quantification of cells cultured on 96-well plates
34. Rapid characterization of growth-arrest genes in transient transfection assays
35. Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors
36. New lipid mixture for efficient lipid-mediated transfection of BHK cells
37. A reliable way of obtaining stable inducible clones
38. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
39. Progesterone receptor in chicken bursa of Fabricius and thymus: Evidence for expression in B-lymphocytes
40. Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells
41. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF
42. Estrogen action via the G protein-coupled receptor, GPR30: Stimulation of adenylyl cydase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis
43. Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells
44. Progesterone inhibits growth and induces apoptosis in breast cancer cells: Inverse effects on Bcl-2 and p53
45. Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells
46. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases
47. Effects of hormone replacement therapy on the mammary gland of surgically post-menopausal cynomolgus macaques
48. Effects of conjugated estrogens, medroxyprogesterone acetate, and tamoxifen on the mammary glands of macaques